QQQ   267.95 (-0.87%)
AAPL   447.95 (-0.66%)
AMZN   3,111.25 (-1.17%)
TSLA   1,393.50 (-1.77%)
BA   184.24 (+2.69%)
QQQ   267.95 (-0.87%)
AAPL   447.95 (-0.66%)
AMZN   3,111.25 (-1.17%)
TSLA   1,393.50 (-1.77%)
BA   184.24 (+2.69%)
QQQ   267.95 (-0.87%)
AAPL   447.95 (-0.66%)
AMZN   3,111.25 (-1.17%)
TSLA   1,393.50 (-1.77%)
BA   184.24 (+2.69%)
QQQ   267.95 (-0.87%)
AAPL   447.95 (-0.66%)
AMZN   3,111.25 (-1.17%)
TSLA   1,393.50 (-1.77%)
BA   184.24 (+2.69%)
Log in

NASDAQ:CYCNCyclerion Therapeutics Stock Price, Forecast & News

$4.89
+0.53 (+12.16 %)
(As of 08/11/2020 09:41 AM ET)
Add
Compare
Today's Range
$4.20
Now: $4.89
$5.09
50-Day Range
$3.46
MA: $4.98
$7.14
52-Week Range
$1.69
Now: $4.89
$14.83
Volume455,240 shs
Average Volume304,405 shs
Market Capitalization$165.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.01
There is no company description available for Cyclerion Therapeutics Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CYCN
CUSIPN/A
CIKN/A
Phone857-327-8778

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.51 million
Book Value$3.56 per share

Profitability

Net Income$-123,010,000.00
Net Margins-2,006.33%

Miscellaneous

EmployeesN/A
Market Cap$165.87 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
$4.89
+0.53 (+12.16 %)
(As of 08/11/2020 09:41 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CYCN News and Ratings via Email

Sign-up to receive the latest news and ratings for CYCN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cyclerion Therapeutics (NASDAQ:CYCN) Frequently Asked Questions

How has Cyclerion Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Cyclerion Therapeutics' stock was trading at $2.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CYCN stock has increased by 68.6% and is now trading at $4.89.
View which stocks have been most impacted by Coronavirus
.

When is Cyclerion Therapeutics' next earnings date?

Cyclerion Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Cyclerion Therapeutics
.

How were Cyclerion Therapeutics' earnings last quarter?

Cyclerion Therapeutics Inc (NASDAQ:CYCN) released its quarterly earnings results on Monday, August, 3rd. The company reported ($0.70) earnings per share for the quarter. The business had revenue of $0.75 million for the quarter. Cyclerion Therapeutics had a negative net margin of 2,006.33% and a negative return on equity of 102.19%.
View Cyclerion Therapeutics' earnings history
.

Has Cyclerion Therapeutics been receiving favorable news coverage?

News articles about CYCN stock have trended positive this week, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cyclerion Therapeutics earned a news sentiment score of 2.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future.
View the latest news about Cyclerion Therapeutics
.

Are investors shorting Cyclerion Therapeutics?

Cyclerion Therapeutics saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 904,600 shares, a decrease of 13.0% from the July 15th total of 1,040,000 shares. Based on an average daily volume of 242,300 shares, the days-to-cover ratio is presently 3.7 days. Currently, 3.9% of the company's shares are short sold.
View Cyclerion Therapeutics' Short Interest
.

Who are some of Cyclerion Therapeutics' key competitors?

What other stocks do shareholders of Cyclerion Therapeutics own?

What is Cyclerion Therapeutics' stock symbol?

Cyclerion Therapeutics trades on the NASDAQ under the ticker symbol "CYCN."

Who are Cyclerion Therapeutics' major shareholders?

Cyclerion Therapeutics' stock is owned by a variety of institutional and retail investors. Top institutional investors include New York State Common Retirement Fund (0.42%), Russell Investments Group Ltd. (0.10%), State Board of Administration of Florida Retirement System (0.03%) and UBS Group AG (0.02%). Company insiders that own Cyclerion Therapeutics stock include Amy W Schulman, Andreas Busch, Mark G Currie and William Huyett.
View institutional ownership trends for Cyclerion Therapeutics
.

Which institutional investors are selling Cyclerion Therapeutics stock?

CYCN stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG. Company insiders that have sold Cyclerion Therapeutics company stock in the last year include Mark G Currie, and William Huyett.
View insider buying and selling activity for Cyclerion Therapeutics
.

Which institutional investors are buying Cyclerion Therapeutics stock?

CYCN stock was purchased by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, State Board of Administration of Florida Retirement System, and Russell Investments Group Ltd.. Company insiders that have bought Cyclerion Therapeutics stock in the last two years include Amy W Schulman, Andreas Busch, and Mark G Currie.
View insider buying and selling activity for Cyclerion Therapeutics
.

How do I buy shares of Cyclerion Therapeutics?

Shares of CYCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cyclerion Therapeutics' stock price today?

One share of CYCN stock can currently be purchased for approximately $4.89.

How big of a company is Cyclerion Therapeutics?

Cyclerion Therapeutics has a market capitalization of $165.87 million and generates $4.51 million in revenue each year.

What is Cyclerion Therapeutics' official website?

The official website for Cyclerion Therapeutics is www.cyclerion.com.

How can I contact Cyclerion Therapeutics?

Cyclerion Therapeutics' mailing address is 301 BINNEY STREET, CAMBRIDGE MA, 02142. The company can be reached via phone at 857-327-8778 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.